WeedLife News Network

The cannabis business is recently legalised in 20 states of the U.S., and as this business shifts from the black market into the mainstream, it has encountered unparalleled development.

Like every other business, the journey in the legal cannabis business can be fun, invigorating, and yet somewhat overpowering. Thus, following a couple of tips to make the initial steps can help to make a solid establishment and set up a successful business.

The legalization of medical and recreational and marijuana in specific states has provided cannabis business opportunities in the market for bold entrepreneurs and visionaries.

Conducted by research firm Fact.MR, the study highlights the potential growth of the cannabis beverage category.

Worldwide revenues for cannabis-infused drinks reached US$250 million by the end of 2020.

Over the next decade, the market value is predicted to expand to 24 times that, climbing by 38% CAGR from 2021-2031 to approach US$6bn. CBD-based drinks are anticipated to make up three out of every five sales during that period.

“Beginner cannabis users who want a discreet, accessible, and regulated amount of cannabis are driving increased demand for CBD-infused cannabis drinks,” explained a Fact.MR senior research analyst.

Meanwhile, non-alcoholic cannabis-infused beverages are expected to comprise 50% of consumption.

The creators of South Park have signed a new deal with ViacomCBS bosses, worth almost US$1 billion, to expand their cartoon world.

One of the most lucrative in television history, the new US$900 million ($1.1 billion) deal will last over six years and include the series and a second South Park movie, according to Bloomberg.

There are also tie-ins to ViacomCBS’ new streaming service, Paramount+.

Insiders claim creators Trey Parker and Matt Stone have been working on a South Park film for some time, and it is expected to be released on the streaming platform before the end of the year.

It will serve as the follow-up to the pair’s 1999 movie, South Park: Bigger, Longer & Uncut.

New Mexico’s anticipation of a deficit is not paranoia; it is a safe prediction given the precedent set by other states.

When New Mexico started legalizing cannabis, the marijuana community in the state was ecstatic because it marked a new dawn for them. When it finally attained legalized status, the excitement was through the roof, but today it seems like something is threatening that joyful feeling in the state.

The trouble with availability

New Mexico faces a looming crisis and may have trouble with marijuana availability. Experts in the state are saying that recreational marijuana products may run out in the first week when sales begin.

When Philip Morris International (PMI) CEO Jacek Olczak told The Mail on Sunday that the UK government should treat cigarettes like petrol cars and ban them in 10 years, many wondered why the world’s biggest tobacco company would self-sabotage itself with such a draconian statement.

Hemp is a cannabis sativa plant that contains only trace amounts of THC, the psychoactive ingredient typically associated with marijuana.

The market for industrial hemp, which can be used to make a wide variety of products, was estimated to be US$5 billion in 2019 and is forecast to grow to US$36 billion by 2026.

More hemp being turned into more products means more hemp waste, which is the stalk after the leaves, flower and seeds have been removed.

The cannabis industry has gone from budding to booming in the past few years. Recreational cannabis sales are legal in 18 states to date (and Washington, D.C.) and in 2020, Americans spent over $18 billion on legal weed – a 71% increase from the year prior.

Where There’s Smoke…

The production and distribution of cannabis, once known to many only as marijuana, is the newest and most variegated industry in America. Some would even say it is one of the toughest industries in America in which to do business. This article will discuss a few unique challenges from a financial perspective faced by the industry.

The first complexity starts with the difference between cannabis and CBD. When you look at a cannabis plant and a hemp plant side by side, the plants themselves look identical to an untrained eye, making it a bit challenging to identify, as the real difference lies in the chemistry of the plants.

From a dispensary to your front door — that's the promise of Doobie, St. Louis' only cannabis home delivery service, which on July 22 marked its first day of ferrying orders to medical marijuana patients in the metro area.

While the service can feel at first like DoorDash for weed, Doobie presently connects patients only with products at Jane Dispensary (6662 Delmar Boulevard, University City; 314-464-4420). On a recent weekday, the service sent a shiny white van with ice-cooled bags of THC gummies to a residence in south St. Louis.

Four New England states now allow medical and recreational use of marijuana, which means local companies must review their current drug testing and substance use policies to ensure they are compliant with state and federal laws.

With Connecticut legalizing recreational marijuana in June — and Maine, Massachusetts and Vermont laws already in place — only New Hampshire and Rhode Island remain as holdouts for legalization. The provisions of the Connecticut law that affect employers will go into effect on July 1, 2022.

Investors can finally see the first rays of sunlight after a terrible year for this pot grower.

On July 28, Tilray (NASDAQ:TLRY) stock surged by 26% in a single trading day after the company published strong quarterly results -- the first earnings report its $4 billion merger with fellow Canadian pot grower Aphria. Revenue shot up, the company finally turned a profit, and its international expansion has begun to pay off. 

Tilray desperately needed that good news, as its shares are down almost 50% year to date. Let's look at why the future looks bright for this once-beaten-down marijuana company. 

Tammy Turner and Kerry Buffington, the co-owners of Kapstone Employment Services in Detroit, had to have a conversation with a client recently that they're not used to having.

"We actually had to go to them and say, 'Listen, this is not being consistent with the labor market now. Marijuana is legal and you're passing up on good talent,' " Turner remembers telling the client.

Turner said they were interviewing candidates for open positions at this company, and staff at their employment agency ask candidates whether they can pass a drug test as a part of their routine questions. She said, more often than not, candidates are honest and will say whether they would test positive for marijuana.

Consumers and investors alike are excited about the emergence of the cannabis industry in the U.S. Legalization is gaining momentum state by state and social acceptance at the federal level. Specialty retailer GrowGeneration (NASDAQ: GRWG) is a potential stock for investors looking for broad exposure to U.S. cannabis. Here are three reasons why GrowGeneration is positioned to thrive in the coming years.

1. Cannabis laws are rapidly changing

In 2012, Colorado and Washington became the first states to legalize recreational cannabis. Since then, the momentum has picked up across the United States. Recreational cannabis is now legal in 19 states, and 36 have legalized it for medicinal use.

A Greek medical marijuana producer is heading for the London Stock Exchange (LSEG.L) thanks to a SPAC deal to take the company public. 

UK SPAC Plc, a London-listed shell company, said on Monday it had agreed a reverse takeover with Hellenic Dynamics, a European medical cannabis cultivation company. The deal values Hellenic at £45m ($62.5m).

The transaction combines two of the hottest trends in public markets over the last few years: SPACs and cannabis. Both corners of the market have attracted huge amounts of investor attention, as well as some concerns about hype and froth.

When Philip Morris International (PMI) CEO Jacek Olczak told The Mail on Sunday that the UK government should treat cigarettes like petrol cars and ban them in 10 years, many wondered why the world’s biggest tobacco company would self-sabotage itself with such a draconian statement.

More than 100 million U.S. residents already live in a recreational state and 95% of residents live in a state with legal medical weed — so the consumer population is present and growing. (This article originally viewed on Benzinga By Michael Sassano)

Multi-State Operators (MSOs) in the United States are primed for the next big stock amp-up, which could see at minimum a 50 percent move starting as early as late August even without federal legislative movement. As volumes start to pick up this July, US stocks don’t need a special event to bounce off this latest correction. 

The future looked bright for hemp farmers, but the demand for CBD didn’t follow at the expected levels.

Delta-8 and smokable flower are the two products keeping hemp framers alive. The regulatory loophole that has allowed Delta-8 to be sold legally is also causing legal confusion. Delta-8 is a cannabis product that can be derived from hemp, but still give the consumer a light psychotropic experience. Some states have issued restrictions around the product, while others haven’t addressed it at all. Either way, the demand has been a blessing to hemp farmers who planted lots of acres in 2019 expecting a surge in CBD products, only to see the market contract and prices plummet. 

Connecticut will be rolling in heavy green due to its legalization of recreational marijuana, according to the state’s Office of Fiscal Analysis.

The OFA projects that the medical marijuana industry will generate $3.1 million in sales during fiscal year 2022 – which runs from July 1, 2021 through June 30, 2022 – and another $1 million in municipal taxes.

Retail sales are expected to begin in Connecticut by the end of 2022, with the result that FY23 will generate $20.4 million in sales and another $5.9 million in municipal taxes, all of which will go to the general fund.

Hemp Seed Market with 2021: Emerging Technologies, Sales Revenue, Key Players Analysis, Development Assessment and Industry Expansion Strategies 2027